Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01901536 · ClinicalTrials.gov registry record · NA
Family Foundations Coparenting Pilot Trial
A NA study, sponsored by Penn State University.
- Completed
- Registry status
- NA
- Development phase
- 497
- Enrollment target
NCT01901536: Completed NA study, sponsored by Penn State University.
NCT01901536 is a NA study that has completed, run by Penn State University. The registered enrollment target is 497 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (65% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01901536, a NA study, has completed, sponsored by Penn State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 497 participants
- Enrollment target
Study Summary
This is a research study to evaluate the effectiveness of the Family Foundations program and to better understand how families cope with having a new baby. The research questions include: What is the effectiveness of the Family Foundations program? How do families cope with having a new baby?
Primary Outcome
We assessed coparenting relationship quality with the 31-item Coparenting Scale, which was created based on prior work (e.g., Abidin \& Brunner, 1995; Cordova, 2001; Frank, Olmstead, Wagner,\& Laub, 1991; Margolin et al., 2001; McHale, 1997). The overall score represents an average of items covering theoretically important domains: coparental agreement, support,undermining, and exposure of the child to conflict.
Interventions
- BEHAVIORAL Family Foundations Coparenting Program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 497 participants |
| Start Date | 2002-12 |
| Est. Completion | 2007-11 |
| Phase | NA |
What the finished NCT01901536 record still lists
NCT01901536 is an interventional study that assigns participants to a tested intervention. The registered 497 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (65% lower).
The record links to 0 conditions, and to 1 intervention - of which Family Foundations Coparenting Program is the first listed.
NCT01901536 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01901536 about?
NCT01901536 is a clinical study titled "Family Foundations Coparenting Pilot Trial". This is a research study to evaluate the effectiveness of the Family Foundations program and to better understand how families cope with having a new baby. The research questions include: What is the effectiveness of the Family Foundations program? How do families cope with having a new baby?
What is the current status of trial NCT01901536?
This trial is currently completed. It is a NA study. The enrollment target is 497 participants. The study started on 2002-12. Estimated completion is 2007-11.
What interventions are being tested in trial NCT01901536?
The interventions under investigation include: Family Foundations Coparenting Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT01901536?
This trial is sponsored by Penn State University, which has 219 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01901536's enrollment target sits among peer trials
497 213th of 2000 higher than 1,788 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03175224 · 497 participants · Phase 2
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
- NCT05301816 · 497 participants · NA
PDN Post Market, Multicenter, Prospective, Global Clinical Study
- NCT05766670 · 497 participants · Phase 3
Intramedullary Calcium Sulfate Antibiotic Depot
- NCT05283720 · 496 participants · Phase 2
A Study to Evaluate Adverse Events and Change in Disease Activity of Subcutaneous (SC) Epcoritamab in Combination With Oral and Intravenous Anti-Neoplastic Agents in Adult Participants With Non-Hodgkin Lymphoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia